Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emisphere Technologies Inc (OTCQB:EMIS)

0.5503
Delayed Data
As of 10:31am ET
 +0.0004 / +0.07%
Today’s Change
0.20
Today|||52-Week Range
0.90
+96.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$33.4M

Company Description

Emisphere Technologies, Inc,. is a commercial stage specialty pharmaceutical company. It prepares to launch its first prescription product, oral Eligen B12 Rx, which provides a therapeutic equivalent to vitamin B12 injections. It also utilizes its broad-based proprietary oral drug delivery platform, Eligen Technology, to create new oral formulations of therapeutic agents. The company was founded in 1986 and is headquartered in Roseland, NJ.

Contact Information

Emisphere Technologies, Inc.
4 Becker Farm Road
Roseland New Jersey 07068
P:(973) 532-8000
Investor Relations:
(973) 532-8005

Employees

Shareholders

Individual stakeholders31.45%
Mutual fund holders--
Other institutional--

Top Executives

Alan L. RubinoPresident, Chief Executive Officer & Director
Michael R. GaroneCFO, Secretary & Head-Investor Relations
M. Gary I. RileyChief Scientific Officer
Kathleen McDedeDirector-Human Resources & Information Technology
Carlos DeLeceaHead-Global Business Development